AI Bioscience Startup Raising Initial Funds In Vijaywada
Email
Phone
Google
LinkedIn
Facebook
About Business
The company is building a specialized AI platform designed for bioscience researchers, with an initial focus on the Indian market. Its core product, functions as a research-grade AI assistant that integrates multiple scientific databases and analytical tools into a single, unified system. The platform is designed to support researchers in generating structured, reliable, and actionable insights, improving the efficiency and quality of scientific workflows.
Problem Statement
Despite having over 7 lakh bioscience researchers, India lacks accessible and integrated research infrastructure. Existing tools are often expensive, fragmented, and not tailored to Indian research needs. Researchers typically rely on multiple disconnected platforms, leading to inefficiencies, limited collaboration, and slower innovation.
Solution
Orin addresses this gap by offering an AI-driven platform that combines domain-specific reasoning with real-time access to scientific databases. Unlike generic AI tools, it delivers structured outputs aligned with actual research workflows, including mechanism of action, supporting evidence, and clinical relevance. The platform is designed to adapt to user needs and provide more accurate, context-aware insights.
Clientele type
Free access for basic usage
Paid plans for students and individual researchers
Advanced offerings for labs, startups, and institutions
Premises
They are working remotely.
Asking Price Includes
Stake Offered to be discussed with potential investors.
Asking Price
INR 50.00 L
Minimum ticket size
INR 50.00 L
Reason
The company is raising funds to accelerate product development and establish an early foothold in a fast-growing and underserved market. The bioscience research ecosystem in India is expanding, but lacks accessible and integrated digital infrastructure, creating a strong opportunity for early entrants.
Keywords
Business Tags
Fundraising for ₹10 Cr – 500 Cr
Confidential Process Completed in 120 Days
Strategic Preparation, Aligned Investor Outreach and Seamless Closure
Supported by Advisors with 26+ Years of Experience
